Effects of SGLT1/2 Inhibitors on Cardiovascular and Kidney Outcomes in Type 2 Diabetes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
American Heart Journal
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Effects of Sodium-Glucose Cotransporter 1 and 2 Inhibitors on Cardiovascular and Kidney Outcomes in Type 2 Diabetes: A Meta-Analysis Update
Am. Heart J 2020 Dec 29;[EPub Ahead of Print], HM Salah, SJ Al'Aref, MS Khan, M Al-Hawwas, S Vallurupalli, JL Mehta, JP Mounsey, SJ Greene, DK McGuire, RD Lopes, M FudimFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.